Onesource Specialty Pharma

Onesource Specialty Pharma

1,877.10
-19.00
(-1.00%)
Market Cap
21,480.80 Cr
EPS
-1.63
PE Ratio
240.85
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
2,248.00
52 Week Low
1,209.95
PB Ratio
3.66
Debt to Equity
1.22
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,641.40
#1 3,93,826.80
34.36
#1 54,729.00
9.71
#1 10,980
-19.84
46.65
6,132.50
1,62,798.60
70.57
9,712.00
18.67
2,191
26.74
37.51
1,564.00
1,26,325.50
23.42
28,409.50
7.12
5,291
9.88
62.75
3,623.00
1,22,618.80
60.70
11,539.40
6.99
1,911
19.91
57.93
1,260.40
1,05,189.30
#1 18.50
33,741.20
16.73
5,725
1.26
53.20
2,472.60
1,02,051.30
53.98
12,744.20
#1 20.90
2,007
-18.14
44.22
988.80
99,496.40
21.34
23,511.00
18.55
4,615
2.60
57.97
1,961.60
89,585.40
24.20
22,909.50
13.74
3,306
#1 51.64
53.80
33,265.00
70,685.80
48.63
6,684.70
9.64
1,414
11.55
48.48
5,347.50
63,937.40
28.11
13,458.30
3.70
2,216
21.39
68.13

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
325.36 %
Net Income Growth
-12.01 %
Cash Flow Change
34.18 %
ROE
74.62 %
ROCE
26.56 %
EBITDA Margin (Avg.)
-87.50 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
10
34
88
76
296
338
399
429
333
Expenses
80
105
173
76
233
263
351
244
242
EBITDA
-70
-71
-85
-0
64
76
48
185
91
Operating Profit %
-800 %
-210 %
-207 %
-4 %
20 %
21 %
11 %
43 %
26 %
Depreciation
19
18
20
20
68
68
69
69
68
Interest
18
25
26
21
42
45
46
33
28
Profit Before Tax
-107
-114
-130
-40
-47
-38
-67
83
-4
Tax
0
0
0
0
-41
5
2
-16
-4
Net Profit
-107
-114
-130
-40
-6
-42
-69
99
-0
EPS in ₹
0.00
-27.37
-31.32
-9.67
-0.51
-10.13
-6.31
8.61
-0.02

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
1,258
2,442
2,009
1,309
7,550
Fixed Assets
633
1,231
1,361
863
2,508
Current Assets
99
511
228
176
1,086
Capital Work in Progress
431
490
335
188
60
Investments
0
0
5
20
158
Other Assets
195
722
309
238
0
Total Liabilities
1,258
2,442
2,009
1,309
7,550
Current Liabilities
161
809
865
631
1,114
Non Current Liabilities
321
621
358
282
556
Total Equity
776
1,013
786
396
5,881
Reserve & Surplus
775
1,009
781
392
5,869
Share Capital
2
3
4
4
11

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
56
55
-112
13
Investing Activities
-207
-692
-68
511
Operating Activities
-118
-416
-163
-107
Financing Activities
381
1,162
118
-391

Share Holding

% Holding
Dec 2024
Mar 2025
Jun 2025
Promoter
37.77 %
34.25 %
29.79 %
FIIs
17.44 %
18.54 %
18.69 %
DIIs
12.56 %
18.04 %
18.10 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
13.05 %
12.50 %
13.25 %
Others
19.18 %
16.67 %
20.17 %
No of Share Holders
98,425
82,712
87,760

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Aug 2025 1,995.05 1,847.80
05 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 May 2025 1,593.85 1,593.00
29 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jan 2025 0.00 1,536.60
06 Dec 2024 MERGER - DEMERGER Merger - Demerger
2:1
06 Dec 2024 0.00 0.00
14 Feb 2024 CHANGE OF NAME Change Of Name
NA
14 Feb 2024 0.00 0.00

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript5 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
General UpdateAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2025
General UpdatesAug 04, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 04, 2025
Board Meeting Outcome for The Board Has Approved Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Aug 04, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Board Meeting Intimation for Approval Of The Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025Jul 29, 2025
General-UpdatesJul 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 07, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 07, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 30, 2025
Closure of Trading WindowJun 27, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 23, 2025
General-UpdatesJun 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 16, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 16, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 10, 2025
General-UpdatesJun 10, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 04, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 12, 2025
Announcement Under Regulation 30.May 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2025
Intimation Of Investor Meet Held On May 06 2025May 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 05, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 29, 2025
Board Meeting Intimation for Prior Intimation Of Board MeetingApr 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 26, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 25, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressApr 23, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2025
Update On Scheme Of ArrangementApr 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 10, 2025
Announcement Under Regulation 30 SEBI(LODR) Regulations 2015_UpdatesApr 09, 2025

Technical Indicators

RSI(14)
Neutral
41.29
ATR(14)
Less Volatile
63.40
STOCH(9,6)
Neutral
38.58
STOCH RSI(14)
Neutral
44.51
MACD(12,26)
Bearish
-4.80
ADX(14)
Weak Trend
23.42
UO(9)
Bearish
64.20
ROC(12)
Downtrend And Accelerating
-4.68
WillR(14)
Neutral
-74.55

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Quant Multi Cap Fund Direct-Growth
0.00%
-711000
-1.54%
-1.38%
Quant Small Cap Fund Direct Plan-Growth
0.76%
-540058
-0.48%
-0.38%
Axis Small Cap Fund Direct-Growth
0.81%
456335
0.30%
0.34%
Axis Flexi Cap Fund Direct-Growth
0.98%
264000
0.34%
0.40%
Motilal Oswal Large and Midcap Fund Direct - Growth
2.96%
133643
-0.26%
0.33%
Aditya Birla Sun Life Value Direct Fund-Growth
1.31%
118396
0.32%
0.42%
Quant Business Cycle Fund Direct-Growth
0.00%
-107500
-1.76%
-1.55%
Motilal Oswal Balanced Advantage Fund Direct-Growth
0.00%
-99950
-2.41%
-2.60%
TRUSTMF Small Cap Fund Direct-Growth
0.94%
50266
0.94%
0.94%
TRUSTMF Flexi Cap Fund Direct - Growth
0.67%
37726
0.67%
0.67%
Motilal Oswal Business Cycle Fund Direct-Growth
1.51%
-25663
-0.47%
-0.25%
JM Small Cap Fund Direct - Growth
2.65%
7736
0.05%
0.24%
Axis Equity Savings Fund Direct-Growth
0.36%
5000
0.08%
0.11%
Motilal Oswal Active Momentum Fund Direct - Growth
3.36%
3710
-0.26%
-0.09%
Bandhan Midcap Fund Direct-Growth
0.49%
3166
-0.01%
0.22%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.49%
-1886
-0.24%
0.49%
JM Focused Direct Plan-Growth
2.91%
832
-0.20%
0.08%
Mirae Asset Balanced Advantage Fund Direct - Growth
0.54%
0
-0.06%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
JM ELSS Tax Saver Fund Direct Plan-Growth
2.69%
0
-0.28%
-0.04%
JM Flexicap Fund Direct Plan-Growth
1.39%
0
-0.11%
0.03%
ITI Large & Mid Cap Fund Direct-Growth
0.61%
0
-0.04%
0.02%
JM Large Cap Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%
JM Midcap Fund Direct - Growth
1.94%
0
-0.19%
0.01%
Groww Nifty Total Market Index Fund Direct - Growth
0.00%
0
0.00%
0.00%